Press Release

BillionToOne's Northstar Select® Demonstrates Superior Sensitivity in Prospective Head-to-Head Validation Study Publication

August 26, 2025

BillionToOne Announces Medicare Coverage for Northstar Select®

BillionToOne’s Northstar Response® Validated in New Peer-Reviewed Study, Building on Previous Clinical Research

BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

January 23, 2023

BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSD

Act with certainty. Adapt with precision.